Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL35589 | 0.90 | — | — | |
| Ammonia Solution, Strong SCHEMBL27894735 | 0.87 | — | — | |
| SCHEMBL30888177 | 0.87 | — | — | |
| SCHEMBL9773632 | 0.83 | TDP1 (0.33) | TDP1LMNA | |
| Ethylene Glycol SCHEMBL860665 | 0.82 | TDP1 (0.75) | TDP1LMNAALOX15BLMPMP22 | |
| Ethylene Glycol SCHEMBL1275662 | 0.82 | TDP1 (0.75) | TDP1LMNAALOX15BLMPMP22 | |
| Phosphoric Acid SCHEMBL16371968 | 0.81 | TDP1 (0.32) | TDP1 | |
| Acetone SCHEMBL1788346 | 0.81 | TDP1 (0.57) | TDP1LMNAALOX15BLMPMP22 | |
| Phosphoric Acid SCHEMBL16372120 | 0.81 | TDP1 (0.32) | TDP1 | |
| SCHEMBL28170977 | 0.81 | TDP1 (0.57) | TDP1LMNAALOX15BLMPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7176297-B2 | Photoactivatable silane compounds and methods for their synthesis and use | AFFYMETRIX, INC. (US) | 2007-02-13 | — | — | US | claimed |
| US-20040234788-A1 | Photoactivateable silane compounds and methods for their synthesis and use | AFFYMETRIX, INC. | 2004-11-25 | — | — | US | claimed |
| US-6773888-B2 | ARRAY OF OLIGONUCLEOTIDES; FUNCTIONALIZED POLYMER, A PHOTOACTIVATABLE SILANE COMPOUND CAPABLE OF PHOTOCHEMICALLY CROSS-LINKING TO SAID FUNCTIONALIZED POLYMER. | AFFYMETRIX, INC. | 2004-08-10 | — | — | US | claimed |
| WO-2003087166-A2 | PHOTOACTIVATABLE SILANE COMPOUNDS AND METHODS FOR THEIR SYNTHESIS AND USE | AFFYMETRIX, INC. (US) | 2003-10-23 | — | — | WO | claimed |
| US-20030194715-A1 | Photoactivatable silane compounds and methods for their synthesis and use | AFFYMETRIX, INC. (US) | 2003-10-16 | — | — | US | claimed |
| US-7176297-B2 | Photoactivatable silane compounds and methods for their synthesis and use | AFFYMETRIX, INC. (US) | 2007-02-13 | — | — | US | disclosed |
| US-20040234788-A1 | Photoactivateable silane compounds and methods for their synthesis and use | AFFYMETRIX, INC. | 2004-11-25 | — | — | US | disclosed |
| US-6773888-B2 | ARRAY OF OLIGONUCLEOTIDES; FUNCTIONALIZED POLYMER, A PHOTOACTIVATABLE SILANE COMPOUND CAPABLE OF PHOTOCHEMICALLY CROSS-LINKING TO SAID FUNCTIONALIZED POLYMER. | AFFYMETRIX, INC. | 2004-08-10 | — | — | US | disclosed |
| WO-2003087166-A2 | PHOTOACTIVATABLE SILANE COMPOUNDS AND METHODS FOR THEIR SYNTHESIS AND USE | AFFYMETRIX, INC. (US) | 2003-10-23 | — | — | WO | disclosed |
| US-20030194715-A1 | Photoactivatable silane compounds and methods for their synthesis and use | AFFYMETRIX, INC. (US) | 2003-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030194715-A1 | Photoactivatable silane compounds and methods for their synthesis and use | PCNA, GMNN, LSS | TDP1 4201/4885LMNA 13/4885ALOX15 920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.